Ligon Discovery Secures $500,000 New Funding

  • Feed Type
  • Date
  • Company Name
    Ligon Discovery
  • Mailing Address
    64 Sidney Street Cambridge, MA 02139
  • Company Description
    Ligon Discovery’s primary technology platform, Small-Molecule Microarrays (SMMs), fundamentally transforms drug discovery by bringing the power of microarrays to target screening.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.